Equities

Morepen Laboratories Ltd

MOREPENLAB:NSI

Morepen Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)86.36
  • Today's Change2.76 / 3.30%
  • Shares traded11.94m
  • 1 Year change+135.31%
  • Beta1.4810
Data delayed at least 15 minutes, as of Sep 20 2024 11:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income1,3545581,267
Depreciation/depletion335279276
Non-Cash items7.28(0.26)(82)
Cash taxes paid, supplemental381166249
Cash interest paid, supplemental------
Changes in working capital(962)(1748)(2064)
Total cash from operations734(912)(578)
INVESTING
Capital expenditures(813)(460)(674)
Other investing and cash flow items, total(20)(5.37)357
Total cash from investing(833)(465)(317)
FINANCING
Financing cash flow items14(2.04)98
Total cash dividends paid------
Issuance (retirement) of stock, net01,372525
Issuance (retirement) of debt, net386615
Total cash from financing521,435639
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash(47)59(256)
Net cash-begin balance/reserved for future use217158414
Net cash-end balance/reserved for future use169217158
SUPPLEMENTAL INCOME
Depreciation, supplemental335279276
Cash interest paid, supplemental------
Cash taxes paid, supplemental381166249
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.